MediKarma, a San Ramon, CA-based provider of AI-driven preventive healthcare platforms, acquired Nanell, a Nagoya, Japan-based provider of digital pregnancy journey solutions, from Niterra Co., Ltd.
The deal amount was not disclosed.
Read More:Sherpas Raises $3.2M in Seed Funding
With this deal, MediKarma will expand its women’s health services and value-based care by adding specialised pregnancy tracking and guided resources to its patient profiles. Integrating Nanell’s pregnancy solution into MediKarma’s platform also strengthens its B2B2C approach.
“This acquisition speeds up MediKarma’s growth in women’s health with a solution designed for the critical moments between visits,” said Kris Narayan, CEO of MediKarma. “By adding Nanell’s pregnancy expertise, we give members clearer, real-time guidance and share important information with care teams. This strengthens value for payors and employers with earlier risk insights and provides a more proactive, supportive experience for families at an important stage of life.”
Nanell was created by Niterra Ventures, part of Niterra Co., Ltd., to offer expert advice, guided resources, and health tracking. It has shown strong early results, including support for first-time and high-risk pregnancies, with retention rates higher than the industry average.
MediKarma, an AI-powered platform that unifies patient data to support proactive care, is integrating Nanell’s pregnancy solution into its system. This strengthens MediKarma’s B2B2C strategy. Members get clear guidance and timely support from a single source. At the same time, partner organisations gain earlier risk insights, improved contract performance, and lower avoidable costs—all from a single, comprehensive patient profile.
Under the agreement, MediKarma will acquire Nanell’s IP and related assets, with a 60–90 day knowledge transfer and operational handover. The deal includes an equity-linked payment and a revenue share tied to Nanell’s future growth. Niterra Ventures will also provide support during the transition.
“Niterra Co., Ltd. invests in ventures to improve people’s quality of life. Nanell was created to support women during pregnancy better,” said Dirk Schapeler, President of Niterra Ventures. “We believe MediKarma is the ideal home for Nanell’s next chapter. It links pregnancy insights to a complete patient profile, benefiting both members and care teams. We’re excited to support MediKarma as it grows this capability across B2B and B2C channels.”
About medikarma
Founded in 2021 by CEO Kris Narayan, MediKarma is an AI-driven healthcare company focused on preventive, value-based care. Its platform combines EMR, claims, pharmacy, device and patient-reported data into a complete patient profile, then turns it into actionable workflows for care teams. By connecting insights to action, MediKarma helps organisations close care gaps, lower avoidable costs, and improve member experience, while giving people a clearer view of their health.
About Niterra
Founded by Dirk Schapeler, President of Niterra Ventures Company, Niterra Co., Ltd. is a global manufacturer established in 1936, known for NGK spark plugs and NTK ceramic products. In fiscal 2024 (ending March 2025), the company reported revenues of 652.9 billion yen (4.27 billion USD). Niterra has 31 locations in Japan, 62 overseas and about 16,000 employees worldwide.
Read More:Maazah Raises $2M in Seed Funding
